Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich

References

• Scheiber K, Ackermann D, Studer UE. Bilateral testicular germ cell tumors: a report of 20 cases. J Urol 1987; 138: 73–6
   PubMed Web of Science ®Google Scholar
• Fossa SD, Aass N. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 1989; 63: 531–4
   PubMedGoogle Scholar
• Osterlind A, Berthelsen JG, Abildgaard N, Hansen SO, Hjalgrim H, Johansen B, et al. Risk of bilateral testicular germ cell cancer in Denmark -1984. J Natl Cancer Inst ;83 1960; 1991: 1391–5
   Google Scholar
• Dieckmann K-P, Loy V, Büttner P. Prevalence of bilateral testicular germ cell tumours and early detection based on contralateral testicular intra-epithelial neoplasia. Br J Urol 1993; 71: 340–5
   PubMedGoogle Scholar
• Coogan CL, Foster RS, Simmons GR, Tognoni PG, Roth BJ, Donohue JP. Bilateral testicular tumors. Management and outcome in 21 patients. Cancer 1998; 83: 547–52
   PubMed Web of Science ®Google Scholar
• Che M, Tamboli P, Ro JY, Park DS, Ro S, Amato RJ, et al. Bilateral testicular germ cell tumors. Twenty-year experience at M.D. Anderson Cancer Center. Cancer 2002; 95: 1228–33
   PubMedGoogle Scholar
• Celebi I, Tekgül S, Özen HA, Özgu I, Remzi D. Sequential bilateral germ cell tumours of the testis. Int Urol Nephrol 1995; 27: 183–7
   PubMedGoogle Scholar
• Colls BM, Harvey VJ, Skelton L, Thompson PI, Frampton CM. Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978–1994. J Clin Oncol 1996; 14: 2061–5
   PubMedGoogle Scholar
• Van Basten JA, Hoekstra HJ, van Driel MF, Sleijfer DT, Droste JHJ, Schraffordt Koops H. Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer. Ann Surg Oncol 1997; 4: 342–8
   PubMedGoogle Scholar
• Gerl A, Clemm Ch, Kohl P, Wilmanns W. Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy. Eur Urol 1994; 25: 216–9
   PubMedGoogle Scholar
• Von der Maase H, Rorth M, Walbom-Jorgensen S, Sotensen BL, Christopherson IS, Hold T, et al. Carcinoma in situ of contra-lateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J 1986; 293: 1398–1401
   PubMed Web of Science ®Google Scholar
• Dieckmann K-P, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996; 14: 3126–32
   PubMed Web of Science ®Google Scholar
• Daugaard G, Giwercman A, Skakkebaek NE. Should the other testis be biopsied?. Sem Urol Oncol 1996; 14: 8–12
   PubMedGoogle Scholar
• Herr HW, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors?. J Urol 1997; 158: 1331–4
   PubMed Web of Science ®Google Scholar
• Petersen PM, Giwercman A, Daugaard G, Rorth M, Petersen JH, Skokkebaeh NE, et al. Effect of graded testicular dose of radiotherapy in patients treated for carcinoma-in situ in the testis. J Clin Oncol 2002; 20: 1537–43
   PubMed Web of Science ®Google Scholar
• Classen J, Dieckmann K, Bamberg M, Souchon R, Kliesch S, Kuehn M, et al. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003; 88: 828–31
   PubMedGoogle Scholar
• Dötsch M, Brauers A, Büttner R, Nolte-Ernsting C, Eble MJ, Jakse G. Malignant germ cell tumour of the contralateral testis after radiotherapy for testicular intraepithelial neoplasia. J Urol 2000; 164: 452–3
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Lauke H, Michl U, Winter E, Loy V. Testicular germ cell cancer despite previous local radiotherapy to the testis. Eur Urol 2002; 41: 643–50
   PubMedGoogle Scholar
• Bach DW, Weissbach L, Hartlapp JH. Bilateral testicular tumor. J Urol 1983; 129: 989–91
   PubMedGoogle Scholar
• Kristianslund S, Fossa SD, Kjellevold K. Bilateral malignant testicular germ cell cancer. Br J Urol 1986; 58: 60–3
   PubMedGoogle Scholar
• Thompson J, Williams CJ, Whitehouse JMA, Mead GM. Bilateral testicular germ cell tumors: an increasing incidence and prevention by chemotherapy. Br J Urol 1988; 62: 374–6
   PubMedGoogle Scholar
• Wahl Ch, Hedinger C. Bilaterale Keimzelltumoren des Hodens. Schweiz med Wschr 1988; 12: 427–33
   Google Scholar
• Patel SR, Richardson RL, Kvols L. Synchronous and metachronous bilateral testicular tumors. Mayo clinic experience. Cancer 1990; 65: 1–4
   PubMed Web of Science ®Google Scholar
• Erpenbach K, Derschum W, Reis M, von Vietsch H. Ergebnisse einer engmaschigen Hodentumornachsorge. Urologe [A] 1990; 29: 102–7
   Google Scholar
• Fordham MVP, Mason MD, Blackmore C, Hendry WF, Horwich A. Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 1990; 65: 290–3
   PubMedGoogle Scholar
• Kratzik C, Aiginger P, Kuber W, Riccabona M, Kührer I, Joos H, et al. Risk factor for bilateral testicular germ cell tumors. Does heredity play a role?. Cancer 1991; 68: 916–21
   PubMedGoogle Scholar
• Bokemeyer C, Schmoll HJ, Schöffski P, Harstrick A, Bading M, Poliwoda H. Bilateral testicular tumors: prevalence and clinical implications. Eur J Cancer 1993; 29A: 874–6
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Bonfig R, Derschum W, von Vietsch H, Wilbert DM. A conservative approach to bilateral testicular germ cell tumors. J Urol 1995; 153: 10–3
   PubMed Web of Science ®Google Scholar
• Sonneveld DJA, Schraffordt-Koops H, Sleijfer DT, Hoekstra HJ. Bilateral testicular germ cell tumours in patients with initial stage I disease. Prevalence and prognosis. A single center's 30 years experience. Eur J Cancer 1998; 34: 1363–7
   PubMedGoogle Scholar
• Albers P, Göll A, Bierhoff E, Schoeneich G, Müller SC. Clinical course and histo-pathologic risk factor assessment in patients with bilateral testicular germ cell tumors. Urology 1999; 54: 714–8
   PubMed Web of Science ®Google Scholar
• Tekin A, Aygun YC, Aki FT, Ozen H. Bilateral germ cell cancer of the testis: a report of 11 patients with a long term follow-up. BJU International 2000; 85: 864–8
   PubMedGoogle Scholar
• Van der Poel HG, Sederlaar JPM, Debruyne FMJ, Witjes JA. Recurrence of germ cell tumor after orchiectomy. Urology 2000; 56: 467–73
   PubMedGoogle Scholar
• Ondrus D, Hornak M, Mat'oska J. Bilateral testicular germ-cell tumors – a single centre long-term experience. Int Urol Nephrol 2001; 33: 521–4
   PubMedGoogle Scholar
• Ohyama C, Kyan A, Satoh M, Saito S, Nishimura Y, Imai Y, et al. Bilateral testicular tumors: a report of nine cases with long-term follow-up. Int J Urol 2002; 9: 173–7
   PubMedGoogle Scholar
• Géczi L, Gomez F, Bak M, Bodrogi I. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. J Cancer Res Clin Oncol 2003; 129: 309–15
   PubMedGoogle Scholar
• Pamenter B, De Bono JS, Brown IL, Nandini M, Kaye SB, Russell JH, et al. Bilateral testicular cancer: a preventable problem? Experience from a large cancer center. BJU Int 2003; 92: 43–6
   PubMedGoogle Scholar
• Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol 2003; 169: 2122–5
   PubMed Web of Science ®Google Scholar
• Hoff Wanderas E, Fossa SD, Tretli S. Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 1997; 33: 244–52
   PubMedGoogle Scholar
• Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998; 9: 657–60
   PubMed Web of Science ®Google Scholar
• von Ostau C, Krege S, Hartmann M, Rübben H. Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies. Scand J Urol Nephrol 2001; 35: 430–1
   PubMedGoogle Scholar
• Kliesch S, Bergmann M, Hertle L, Nieschlag E, Behre HM. Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod 1997; 12: 2830–5
   Google Scholar
• Heidenreich A, Vorreuther R, Neubauer S, Zumbe J, Engelmann UH. Paternity in patients with bilateral testicular germ cell tumors. Eur Urol 1997; 31: 246–8
   PubMedGoogle Scholar
• Jacobsen KD, Fossa SD, Bjoro TP, Aass N, Heilo A, Stenwig AE. Gonadal function and fertility in patients with bilateral testicular germ cell malignancy. Eur Urol 2002; 42: 229–38
   PubMed Web of Science ®Google Scholar
• Harland SJ, Cook PA, Fossa S, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 1998; 160: 1353–7
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kolimannsberger C, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377–99
   PubMed Web of Science ®Google Scholar
• Dieckmann K-P, Hamm B, Düe W, Bauer HW. Simultaneous bilateral testicular germ cell tumors with dissimilar histology: case report and review of the literature. Urol Int 1988; 43: 305–9
   PubMed Web of Science ®Google Scholar
• Redmond J, Samaha MA, Charles RS, Vukelja SJ, Faragher D, Tenglin R, et al. Bilateral synchronous testicular germ cell cancer. South Med J 1995; 88: 305–8
   PubMedGoogle Scholar
• Weissbach L. Organ preserving surgery of malignant germ cell tumors. J Urol 1995; 153: 90–3
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Weißbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001; 166: 2161–5
   PubMedGoogle Scholar